Chinese english Germany Japanese Korea

1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate

1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate Struktur
94703-33-0
CAS-Nr.
94703-33-0
Englisch Name:
1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate
Synonyma:
1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate
CBNumber:
CB0972066
Summenformel:
C20H18F2N2O2
Molgewicht:
356.37
MOL-Datei:
94703-33-0.mol
Request For Quotation

1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate Eigenschaften

Sicherheit

1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate Chemische Eigenschaften,Einsatz,Produktion Methoden

1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aagile Labs Division of Tyger Scientific --
 tygersci@yahoo.com United States 6575 68
Service Chemical Inc. --
 sales@chemos-group.com Germany 6373 71
APAC Pharmaceutical, LLC --
 sales@apacpharma.com United States 6332 38
Shanghai Weile Chemical Technology Co., Ltd --
 sales@weilesci.com China 582 34

94703-33-0()Verwandte Suche:

1-(2-Fluorphenyl)aceton
  • 1-(4-Dimethylamino-2-fluoro-phenyl)-3-(4-dimethylimmonium-2-fluoro-cyclohexa-2,5-dien-1-ylidene)-2-oxo-cyclobuten-4-olate
  • 94703-33-0
  • electronic
Copyright 2019 © ChemicalBook. All rights reserved